| Patents for A61P 23 - Anaesthetics (4,141) |
|---|
| 07/31/2003 | WO2003034988A3 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 07/31/2003 | US20030144356 Formulation |
| 07/31/2003 | US20030144247 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance |
| 07/31/2003 | US20030143249 Method of treating pain |
| 07/31/2003 | CA2474292A1 Sustained release pharmaceutical composition |
| 07/30/2003 | CN1116031C Emulsified inhalational anaesthetic for intravenous injection and its preparation |
| 07/29/2003 | US6599906 Administering to dental pulp or a trigeminal nerve region of the mammal a first injection of a composition comprising a local anesthetic; and a compound that binds to an SS1 or SS2 subunit of a sodium channel, such as tetrodotoxin |
| 07/24/2003 | WO2003059255A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 07/24/2003 | US20030138489 An aqueous solution comprising of propofol, poloxamers; noncontamination, stability |
| 07/23/2003 | EP1328252A2 Transdermal pharmaceutical delivery composition |
| 07/23/2003 | CN1432012A Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 07/23/2003 | CN1431964A Methods of producing terminally sterilized topical patch preparation |
| 07/17/2003 | WO2003057153A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 07/17/2003 | US20030134810 Delivery of pharmacologically active agents associated with polymeric biocompatible materials. Compositions comprising a first, negatively charged pharmacologically active agent such as an oligonucleotide and a polycationic polymer such as |
| 07/16/2003 | EP1327630A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
| 07/16/2003 | EP1326601A2 The use of melatonin for induction of general anesthesia |
| 07/16/2003 | EP0814793B1 Prilocaine and hydrofluorocarbon aerosol preparations |
| 07/16/2003 | CN1430503A O/W emulsion |
| 07/15/2003 | US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/15/2003 | US6591872 Process and plant for the dynamic packaging of gases, especially those for medical use |
| 07/10/2003 | WO2003055465A1 Preparation for the topical anaesthesia of the skin |
| 07/10/2003 | US20030130359 Anesthetic comprising sevoflurane, enflurane, isoflurane, methoxyflurane, and/or desflurane stabilized with water, butylated hydroxytoluene, methylparaben, propylparaben, propofol, and thymol |
| 07/10/2003 | US20030130295 Substituted 2-aminoacetamides and the use thereof |
| 07/10/2003 | US20030130267 Midazolane maleate in water, alcohol solution |
| 07/10/2003 | US20030130225 Urogenital disorders; concurrent administering fluconazole by mouth and topical applying fungicide in situ |
| 07/10/2003 | US20030130211 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 07/09/2003 | EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 07/09/2003 | EP1324992A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 07/09/2003 | EP1098871B1 alpha-AMINO ACID PHENYL ESTER DERIVATIVES |
| 07/09/2003 | CN1113856C New [(3-alkoxy-phenoxy)-ethyl] dialkylamine derivatives and their use as local anaesthetics |
| 07/03/2003 | US20030124190 Methods and compositions for treating pain of the mucous membrane |
| 07/02/2003 | EP1323422A1 Pharmaceutical composition comprising midazolam for buccal administration |
| 07/01/2003 | US6585997 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 06/26/2003 | WO2003051888A1 6-aminomorphinane derivatives, method for the production and use thereof |
| 06/26/2003 | WO2003051855A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 06/26/2003 | WO2003051819A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 06/26/2003 | WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 06/26/2003 | WO2003030920A9 An antispasmodic agent spaced drug delivery system |
| 06/26/2003 | US20030119842 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 06/26/2003 | US20030119810 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
| 06/26/2003 | US20030119790 Substituted phenol compounds useful for anesthesia and sedation |
| 06/26/2003 | CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 06/25/2003 | EP1320369A1 A method of analgesia |
| 06/25/2003 | CN1426397A Aminopyridines and their use as anticonvulsants and sodium channel blockers |
| 06/19/2003 | WO2003049768A1 Selective anesthetic agents and methods of identifying the same |
| 06/19/2003 | US20030113366 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 06/18/2003 | EP1318825A2 Plant extract |
| 06/18/2003 | EP1318797A1 Volatile anaesthetic with xenon |
| 06/18/2003 | EP0821588B1 Levobupivacaine and its use as an anaesthetic in pregnant women |
| 06/12/2003 | US20030109521 Aryl substituted thiazolidinones and the use thereof |
| 06/11/2003 | EP1317926A1 Xenon inhalant for pain treatment |
| 06/11/2003 | EP0973741B1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 06/10/2003 | US6576791 Local anesthetic compounds and uses |
| 06/05/2003 | US20030105110 Novel compounds |
| 06/05/2003 | US20030104065 Method of preparing solid dispersions |
| 06/05/2003 | US20030104046 High-concentration lidocaine compositions and methods for their preparation |
| 06/04/2003 | EP1315731A1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| 06/04/2003 | CN1422270A Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 06/04/2003 | CN1422257A Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker |
| 06/04/2003 | CN1422254A Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 05/28/2003 | CN1420790A Transporters and drug delivery system by using same |
| 05/22/2003 | WO2003041648A2 High-concentration lidocaine compositions and methods for their preparation |
| 05/22/2003 | US20030096811 Such as cis-(4-dimethylaminomethyl-3-hydroxy-3-(3-methoxy-phenyl)-cyclohexanone for treatment of pain, inflammation, allergies, depression, drug/alcohol abuse, gastritis, itching, cardiovascular/repiratory diseases, epilepsy, and diarrhea |
| 05/22/2003 | CA2467167A1 High-concentration lidocaine compositions and methods for their preparation |
| 05/21/2003 | EP0981348B1 The use of levobupivacaine in paediatric surgery |
| 05/21/2003 | EP0981347B1 The use of levobupivacaine in facial surgery |
| 05/20/2003 | US6566356 3-amido or 3-sulfonylamino azetidine compounds and their preparation; high affinity for cannabinoid receptor CB1 type, useful in treating central nervous system, immune, gastrointestinal or cardiovascular disorders, drug abuse |
| 05/15/2003 | US20030091620 Transdermal drug delivery systems containing quaternary ammonium salts and methods of using the same |
| 05/14/2003 | EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 05/14/2003 | CN1108156C Long-acting analgesic used mainly for operational cut and traumatic wound |
| 05/13/2003 | US6562855 Comprises a formulation. The formulation comprises an NMDA antagonist and an alpha-2 adrenergic agonist. In a preferred aspect, there is provided an improved anaesthetic comprising an NMDA antagonist and an alpha-2 adrenergic agonist. |
| 05/08/2003 | WO2003037879A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds |
| 05/08/2003 | WO2003037873A1 Substituted benzo[b]azepin-2-one compounds |
| 05/08/2003 | WO2003037863A2 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 05/08/2003 | WO2002024715A3 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 05/08/2003 | CA2465236A1 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 05/08/2003 | CA2465061A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds |
| 05/08/2003 | CA2464191A1 Substituted benzo[b]azepin-2-one compounds |
| 05/07/2003 | EP0998287B1 Use of levobupivacaine |
| 05/07/2003 | CN1416337A Anaesthetic formulations |
| 05/07/2003 | CN1107504C Use of leveobupivacaine in paediatric surgery |
| 05/02/2003 | EP1221939A4 Ortho ester lipids |
| 05/02/2003 | EP0999840B1 Use of a draflazine analogue for treating pain |
| 05/01/2003 | WO2003035684A1 Ee3-protein family and corresponding dna sequences |
| 05/01/2003 | WO2003034988A2 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 05/01/2003 | WO2003034900A2 Sterile, breathable patch for treating wound pain |
| 05/01/2003 | US20030082225 Sterile, breathable patch for treating wound pain |
| 05/01/2003 | US20030082214 Oil in water emulsion containing antidepressant, anesthetics |
| 05/01/2003 | CA2464344A1 Ee3-protein family and corresponding dna sequences |
| 05/01/2003 | CA2463309A1 Sterile, breathable patch for treating wound pain |
| 04/29/2003 | CA2123160C Controlled release formulation |
| 04/24/2003 | WO2003033048A2 Drug delivery system for conscious sedation |
| 04/24/2003 | WO2003032985A2 Concomitant oral and topical administration of anti - infective agents |
| 04/24/2003 | CA2463754A1 Concomitant oral and topical administration of anti - infective agents |
| 04/23/2003 | EP0941085B1 Device for electrically assisted delivery of agents such as lidocaine and epinephrine |
| 04/23/2003 | CN1106192C Oil in water emulsions containing 2,6,-diisopropyl phenic and ehtylenedinamine-tetraacetic salt |
| 04/22/2003 | US6552064 Side effect reduction |
| 04/22/2003 | CA2287054C 1,3,8-triazaspiro¬4,5|decanone compounds as orl1-receptor agonists |
| 04/17/2003 | WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | WO2003030920A1 An antispasmodic agent spaced drug delivery system |